Brigid S. Boland

Dr. Brigid S. Boland

Gastroenterology
200 W Arbor Dr, 
San Diego, CA 
Offers Telehealth
18 Years of Experience
200 W Arbor Dr, 
San Diego, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Brigid Boland is a Gastroenterologist in San Diego, California. Dr. Boland has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in Gastrectomy. Her top areas of expertise are Ulcerative Colitis, Crohn's Disease, Hemorrhagic Proctocolitis, Colonoscopy, and Endoscopy.

Her clinical research consists of co-authoring 120 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2008
Specialties
Gastroenterology
Licenses
Internal Medicine in CA
Hospital Affiliations
Uc San Diego Health Hillcrest - Hillcrest Med Ctr
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

REGENTS OF THE UNIVERSITY OF CALIFORNIA
200 W Arbor Dr, San Diego, CA 92103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: September 05, 2023
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

120 Total Publications

Editorial: Remission Ambition-How Far Should We Push in Older Adults?
Editorial: Remission Ambition-How Far Should We Push in Older Adults?
Journal: Alimentary pharmacology & therapeutics
Published: November 02, 2025
Similar Doctors
Distinguished in Gastrectomy
Dr. Michael Lajin
Gastroenterology
Distinguished in Gastrectomy
Dr. Michael Lajin
Gastroenterology

Emergency And Acute Care Medical Corporation

435 H St, 
Chula Vista, CA 
 (9.6 miles away)
619-691-7000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Lajin is a Gastroenterologist in Chula Vista, California. Dr. Lajin is rated as a Distinguished provider by MediFind in Gastrectomy. His top areas of expertise are Bile Duct Stricture, Cholestasis, Bile Duct Obstruction, Endoscopy, and Gastrectomy.

Advanced in Gastrectomy
Dr. Indraneel Chakrabarty
Gastroenterology
Advanced in Gastrectomy
Dr. Indraneel Chakrabarty
Gastroenterology

Trinity Medical Multi-Specialty Group Inc.

44274 George Cushman Ct, Suite 208, 
Temecula, CA 
 (50.6 miles away)
951-501-4200
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Indraneel Chakrabarty is a Gastroenterologist in Temecula, California. Dr. Chakrabarty is rated as a Distinguished provider by MediFind in Gastrectomy. His top areas of expertise are Hiatal Hernia, Congenital Diaphragmatic Hernia, Gastroesophageal Reflux Disease (GERD), Gastrectomy, and Colonoscopy.

Advanced in Gastrectomy
Dr. Mark Johnson
Gastroenterology
Advanced in Gastrectomy
Dr. Mark Johnson
Gastroenterology
480 4th Ave, Suite 506, 
Chula Vista, CA 
 (9.6 miles away)
619-585-0313
Languages Spoken:
English
See accepted insurances

Mark Johnson is a Gastroenterologist in Chula Vista, California. Dr. Johnson is rated as an Advanced provider by MediFind in Gastrectomy. His top areas of expertise are Gastrointestinal Bleeding, Benign Esophageal Stricture, Chronic Erosive Gastritis, Gastrectomy, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Boland's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile